Le Lézard
Classified in: Health, Business
Subjects: PDT, VEN, SBS

Advanced Nutrition Company, Healthycell, Launches Reg CF Crowdfunding Campaign on StartEngine.com


CHARLESTON, S.C., Nov. 10, 2021 /PRNewswire/ -- Healthycell today announced it launched a Regulation CF crowdfunding campaign on StartEngine.com.

This crowdfunding round comes after an oversubscribed $1.5 million Bridge Round led by Keen Growth Capital with participation from Balanced Breakfast Fund.

Healthycell is a nutrition company helping people reach their potential through optimized health. It uses patent-pending MICROGELtm technology to deliver nutrients they can absorb and results they can measure in a pill-free experience they love. Their ingestible gel dietary supplement products are taken straight from the gel pack, mixed into drinks, or blended into smoothies.

The nutrition industry company was selected as one of only 7% of applicants to Newchip's competitive accelerator program. It is currently in discussions with several major pharmacy chains and retailers nationwide to grow its B2B channel sales. The D2C channel remains strong with over 2,000 new customers acquired per month and growing, a sustainable cost per acquisition, and a strong customer lifetime value.

"We believe the future of human nutrition lies at the intersection of three core pillars: (1) Pill-free, ultra-absorption delivery systems, (2) Validation on an N=1 basis with personalized biomarker test kits, and (3) Personalization of human nutrition," commented Healthycell Founder and CEO, Douglas Giampapa. "We are working to blend all three pillars into a cohesive offering for our customers."

Visit StartEngine.com, which contains important information and disclosures, including financial statements and risk factors.                                                             

About Healthycell 

About MICROGELtm 

To learn more, visit healthycell.com, Twitter, Facebook, and Instagram.

Media Contact:
Douglas Giampapa
973-433-9585
[email protected]

SOURCE Healthycell


These press releases may also interest you

at 03:00
ARTHEx Biotech S.L., a clinical-stage biotechnology company focused on developing innovative medicines through the modulation of microRNAs, today announced an oral presentation at the upcoming Oligonucleotide & Peptide Therapeutics (TIDES) Conference...

at 02:32
With every successive year, the lines between medical devices and consumer electronics become increasingly blurred ? medtech companies seek to expand their reach beyond patients, and consumer electronics companies have targeted medical applications...

18 avr 2024
The 31st Canadian Cancer Society (CCS) Daffodil Ball, which took place this evening at Windsor Station in Montreal, raised $1,474,785 to fund innovative research projects and essential support programs for people living with cancer. The largest...

18 avr 2024
The report titled "Clinical Trials Matching Software Market by Functionality (Analytics & Reporting, Compliance Tracking, Data Management), Deployment (Cloud & Web Based, On-Premise), End-Use - Global Forecast 2024-2030" is now available on...

18 avr 2024
South Korea's biotechnology company Hyundai Bioscience (CEO Oh Sang-gi, www.hyundaibioscience.com) announced on April 15 that it would carry out global clinical tests aimed at treating all serotypes of Dengue virus infection....

18 avr 2024
The report titled "Progressive Familial Intrahepatic Cholestasis Treatment Market by Drug Type (Cholestyramine, Rifampicin, Ursodeoxycholic Acid), Distribution Channel (Hospital Pharmacies, Online Pharmacies, Retail Pharmacies), End-Users - Global...



News published on and distributed by: